HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Net Income (Common)
HLS Therapeutics Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Net Income (Common)
-$27.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Net Income (Common)
-CA$4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-31%
|
See Also
What is HLS Therapeutics Inc's Net Income (Common)?
Net Income (Common)
-27.5m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Net Income (Common) amounts to -27.5m USD.
What is HLS Therapeutics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-2%
Over the last year, the Net Income (Common) growth was -17%. The average annual Net Income (Common) growth rates for HLS Therapeutics Inc have been -22% over the past three years , -2% over the past five years .